Submitted by Anonymous (not verified) on 18 April 2024 - 10:06
Human medicines European public assessment report (EPAR): Zinplava, bezlotoxumab, Date of authorisation: 18/01/2017, Revision: 12, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Zinplava, bezlotoxumab, Date of authorisation: 18/01/2017, Revision: 12, Status: Authorised